Sleep Chatbot Intervention for Emerging Black/African American Adults
NCT05956886
Dyssomnias, Glucose Metabolism Disorders
Newark, Delaware, United States
View Trial DetailsNCT Number: NCT00982761
The purpose of this study is to discover the health status of occupational drivers. The health status includes data collection of body mass index, blood pressure, central obesity, anxiety scale scores, smoking habit and related cessation therapy, etc.
Looking for future studies?
Notify Me25 year–64 year
All sexes
Observational
Occupational drivers' health is essential for passengers' safety. However, occupational drivers' health is damaged by long-term sitting and driving, lack of exercise, stress from traffic, and irregular diet. The objectives of this study were to assess the health status of occupational drivers in Taiwan. The measures included blood pressure, central obesity, fasting blood sugar, triglyceride, body mass index (BMI), anxiety scale scores, and metabolic syndrome, etc.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Far Eastern Memorial Hospital
Other
Analysis of Health Status of Occupational Driver
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05956886
Dyssomnias, Glucose Metabolism Disorders
Newark, Delaware, United States
View Trial DetailsNCT07739602
Glucose Metabolism Disorders, Hyperinsulinism
Wroclaw, Poland
View Trial DetailsNCT04057339
Behavior, Fasting
La Jolla, California, United States
View Trial DetailsNCT07702669
Glucose Metabolism Disorders, Hyperinsulinism
Harbin, Heilongjiang, China
View Trial Details